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Abstract
In order to functionally interpret differentially expressed genes or other discov-
ered features, researchers seek to detect enrichment in the form of overrepresenta-
tion of discovered features associated with a biological process. Most enrichment
methods treat the p-value as the measure of evidence using a statistical test such
as the binomial test, Fisher’s exact test or the hypergeometric test. However, the
p-value is not interpretable as a measure of evidence apart from adjustments in
light of the sample size. As a measure of evidence supporting one hypothesis over
the other, the Bayes factor (BF) overcomes this drawback of the p-value but lacks
the minimax optimality of the normalized maximum likelihood (NML) of recent
minimum description length methodology.
On the basis of either of two NMLs, the strength of evidence for enrichment
may be measured by the discrimination information (DI) in the data that favors
the alternative hypothesis over the null hypothesis. One of the NMLs, the normal-
ized maximum conditional likelihood (NMCL), is supported by the conditionality
principle.
We assessed measures of evidence derived from the two NMLs, two BFs and
the p-value for one-sided and two-sided hypothesis comparisons using a gene ex-
pression data set from an experiment on a breast cancer cell line. These measures,
for most GO terms, give the same results for the two-sided hypothesis compari-
son. However, they do not agree as well for the one-sided hypothesis comparison,
in which case the DI based on the NMCL cannot be closely approximated by any
of the faster methods.
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Abstract
In order to functionally interpret differentially expressed genes or other discov-
ered features, researchers seek to detect enrichment in the form of overrepresentation
of discovered features associated with a biological process. Most enrichment meth-
ods treat the p-value as the measure of evidence using a statistical test such as the
binomial test, the χ2 test, Fisher’s exact test or the hypergeometric test. However,
the p-value is not interpretable as a measure of evidence apart from adjustments in
light of the sample size. As a measure of evidence supporting one hypothesis over
the other, the Bayes factor (BF) overcomes this drawback of the p-value but lacks
the minimax optimality of the normalized maximum likelihood (NML) of recent
minimum description length methodology.
On the basis of either of two NMLs, the strength of evidence for enrichment
may be measured by the discrimination information (DI) in the data that favors
the alternative hypothesis over the null hypothesis. One of the NMLs, the normal-
ized maximum conditional likelihood (NMCL), is supported by the conditionality
principle.
∗to whom correspondence should be addressed
1
Hosted by The Berkeley Electronic Press
We assessed measures of evidence derived from the two NMLs, two BFs and the
p-value for one-sided and two-sided hypothesis comparisons using a gene expression
data set from an experiment on a breast cancer cell line. These measures, for most
GO terms, give the same results for the two-sided hypothesis comparison. However,
they do not agree as well for the one-sided hypothesis comparison, in which case
the DI based on the NMCL cannot be closely approximated by any of the faster
methods.
1 Introduction
After the development of the microarray technique, high-throughput genomic, proteomic
and bioinformatics scanning approaches (such as microarray gene expression profiling,
mass spectrometry, ChIP-on-chip, etc.) allow researchers to study tens of thousands
of biological features (such as genes, proteins, single-nucleotide polymorphisms (SNPs),
etc.) simultaneously and find a set of interest features, such as genes expressed differ-
ently under certain biological conditions. However, researchers still face the challenge
of interpreting these features or the relationship of these features biologically or func-
tionally. Given a total population of features, such as genes expressed in a microarray
expression or genes in a whole genome, the problem of testing whether some features
over-represent prior biological or functional information (e.g., GO (Ashburner et al.,
2000), the KEGG (Kanehisa and Goto, 2000), etc.) is called the feature enrichment
problem.
Since 2002, a number of high-throughput enrichment tools such as Onto-Express (Kha-
tri et al., 2002), MAPPFinder (Dennis et al., 2003), GoMinier (Zeeberg et al., 2003),
DAVID (Dennis et al., 2003), etc., were developed to address this problem. In 2005, 14
gene enrichment tools are reviewed by Khatri and Draghici (2005). Moreover, Rivals
et al. (2007) discussed the different formulations of the gene enrichment problem and
their related statistical tests. Huang et al. (2009) studied 68 distinct gene enrichment
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analysis tools and introduced the principal foundation of enrichment analysis, namely
that if a biological function is abnormal in a given study, the genes sharing this biological
function should be highly selected together as a relevant group by the high-throughput
screening technologies. Furthermore, they classified all 68 gene enrichment tools into
three categories, Singular Enrichment Analysis (SEA), Gene Set Enrichment Analysis
(GSEA) and Modular Enrichment Analysis (MEA). See Huang et al. (2009) Table 1 and
Table 2 for details. Irizarry et al. (2009) named the methods of SEA and GSEA, the
overrepresentation and the aggregate score approaches.
In this article, we address the feature overrepresentation problem using gene expres-
sion as a concrete example. Based on a pre-selected interesting gene list in which genes
are differentially expressed (DE) and the reference genes, such as the genes expressed
in a microarray experiment, we consider whether genes in the gene list overrepresent a
specified GO category with respect to the reference genes. For each GO category, based
on Table 1 and Table 2, our null hypothesis is that genes in the gene list do not over-
represent the GO category, which is equivalence that the proportion of the differentially
expressed (DE) genes or equivalently expressed (EE) genes which does or does not in
the GO category are picked from the population randomly. Although we only focus on
genes and GO categories in this paper, our models and methods can also be broadly ap-
plied to other features (e.g., proteins, SNPs) and other databases such as those featuring
metabolic pathways.
The rest of the paper is organized as follows. In Section 2, we review definitions of
the BF and the NML. We construct formulas of two BFs and two NMLs to address the
gene enrichment problem in Section 3. Cancer gene expression data (Scholtens et al.,
2004) are analyzed using two NMLs and a BF in Section 4. Finally, we conclude with a
discussion of the results in Section 5.
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Table 1: The number of DE and EE genes in a GO category
DE genes EE genes Total
in GO category x1 x2 x1 + x2
not in GO category n1 − x1 n2 − x2 n1 + n2 − x1 − x2
Total n1 n2 n1 + n2
Note: xi (i = 1, 2) is the number of DE genes (i = 1) or not DE genes (i = 2) in the
category, ni (i = 1, 2) is the total number of DE genes (i = 1) or not DE genes (i = 2)
on the microarray
Table 2: The proportion of DE and EE genes in a GO category
DE genes EE genes Total
in GO category pi11 pi12 pi1·
not in GO category pi21 pi22 pi2·
Total pi·1 pi·2 1
Note: piij (i, j = 1, 2) is the proportion of DE genes (j = 1) or not DE genes (j = 2)
in (i = 1) or not in (i = 2) the category, pii· is the proportion of DE gene on the
microarray and pi·j is the proportion of not DE gene on the microarray. So pii· = pii1+pii2,
pi·j = pi1j + pi2j ,
∑
i,j∈{1,2} piij = 1.
2 Measures of evidence
2.1 Statistical significance
To date, most of gene enrichment tools address the overrepresentation problem by us-
ing a p-value obtained by applying an exact or approximate statistical test (e.g., Fisher
exact test, hypergeometric test, binomial test, χ2 test, etc.), and Rivals et al. (2007)
reviewed the various p-values for one-side and two-side hypothesis comparisons on the
gene enrichment problem. The p-value has been treated as a measure of evidence which
supports the alternative hypothesis over the null hypothesis following the principle that
smaller p-values correspond to more evidence against the null. Efron et al. (2001) re-
ported the conventional scale of evidence against the null hypothesis H0 in terms of
critical level which is a threshold of the p-value shown in Table 3. The major drawback
of a p-value as a measure of the strength of evidence is that it is not interpretable as
a measure of evidence without considering the sample size (Royall, 1997). For an in-
4
http://biostats.bepress.com/cobra/art76
terpretable measure of evidence, what Royall (2000) called the probability of misleading
evidence converges to 0 if the sample size goes to infinity, i.e.,
PH0(sufficient evidence against H0)→ 0 as n→∞. (1)
To formalize the argument in Royall (1997), Bickel (2010c) argued that a quantity must
satisfy condition (1) to be interpretable as a measure of statistical evidence.
Following the scale in Table 3, we find that, according to the p-value, the probability
of evidence against the null hypothesis does not go to zero but instead remains at the
the critical level (e.g., 0.01 for strong evidence against the null hypothesis) as the sample
size increases. Another disadvantage of viewing the p-value as a measure of the strength
of evidence is that the p-value cannot indicate whether there is the evidence favoring the
null hypothesis; rather, the p-value can only indicate whether there is evidence against
the null hypothesis.
2.2 Strength of statistical evidence
Let X be the random data vector with observed value x. Let Φ0 denote the set of param-
eter values corresponding to a null hypothesis, and let Φ1 denote the set of parameter
values corresponding to the alternative hypothesis. The hypothesis comparison
H0 : φ ∈ Φ0 vs. H1 : φ ∈ Φ1 (2)
is called a simple hypothesis comparison if there is only one element in each Φi for each
i = 1, 2 and called the composite hypothesis comparison otherwise.
The strength of statistical evidence that supports H1 over H0 is
Ev = Ev(Φ1,Φ0;x) =
L1(Φ1;x)
L0(Φ0;x) (3)
5
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Table 3: Conventional scale of evidence Efron et al. (2001)
p-value Evidence against H0
[0.05, 0.1) borderline
[0.025, 0.05) Moderate
[0.01, 0.025) Substantial
[0.005, 0.01) Strong
[0.001, 0.005) Very strong
[0, 0.001) Overwhelming
where Li(Φi;x) for each i = 1, 2, called a generalized likelihood, is a predictive probability
density function evaluated at the observed data vector x. Equation (3) is a generalized
definition of the strength of statistical evidence in favor of the alternative hypothesis
H1 against the null hypothesis H0. It takes different forms depending on various for-
mulas of the hypothesis comparison and generalized likelihood functions. For example,
considering the simple hypothesis comparison, Kullback (1968), using Li({φi};x), the
likelihood function of the parameter φi given observed data x, and calls logarithm of Ev
the information in X = x for discrimination in favor of H1 against H0. If Li(Φi;x) is
the likelihood of the parameter φi integrated over all parameters in Φi, then the strength
of statistical evidence is Bayes factor (BF). Bickel (2010a,b) extended the information
for discrimination to Li(Φi;x) as the normalized maximum likelihood (NML), an op-
timal predictive probability mass function. We define the BF and NML in following
subsections.
2.2.1 Bayes factor
The Bayes factor in principle overcomes the above limitations of the p-value and is a
popular criterion for Bayesian model selection. Assume we are interested in comparing
two hypotheses, H0 and H1, on the observed data vector x. Let Pr(x|Hi) be the proba-
bility density (or mass) of the observed data factor x under the hypothesis Hi (i = 0, 1).
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Table 4: Classical scale of evidence Jeffreys (1948)
log10Ev log2Ev Ev Evidence against H0
(0, 0.5] (0, 1.66] (1, 3.2] Not worth more than a bare mention
(0.5, 1] (1.66, 3.32] (3.2, 10] Substantial
(1, 1.5] (3.32, 4.98] (10, 30] Strong
(1.5, 2] (4.98, 6.64] (30, 100] Very strong
(2,∞) (6.64,∞) (100,∞) Decisive
Table 5: Scale of evidence proposed by Kass and Raftery (1995)
lnEv 2 log2Ev Ev Evidence against H0
(0, 1] (0, 3] (1, 3] Not worth more than a bare mention
(1, 3] (3, 9] (3, 20] Positive
(3, 5] (9, 14] (20, 150] Strong
(5,∞) (14,∞) (150,∞) Very strong
Then the Bayes factor is
Ev =
Pr(x|H1)
Pr(x|H0) =
∫
f1(x;φ1)g1(φ1)dφ1∫
f0(x;φ0)g0(φ0)dφ0
. (4)
where φi (i = 0, 1) is the parameter vector under the hypothesis Hi, gi(φi) (i = 0, 1) is
its prior distribution and fi(x;φi) is the density (or mass) function of the observed data
vector x on the hypothesis Hi.
The Bayes factor can be interpreted as a measure of evidence in favor of one of the
hypotheses for the given data. Jeffreys (1948) and Kass and Raftery (1995) proposed
rules to determine the strength of evidence which can be associated with the observed
value of the Bayes factor (see Tables 4 and 5). It is similar to a likelihood-ratio test but
uses the likelihood integrated over parameters instead of the maximum likelihood over
parameters. It thereby guards against overfitting in a sense of the predictive function
constructed from a sample data poorly fitting the population or another sample data
from the same population. However, the dependence on the prior distribution is a
disadvantage of the Bayes factor as a measure of the strength of evidence (Kass and
Raftery, 1995; Bickel, 2010b).
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2.2.2 Normalized maximum likelihood
Let E be the set of all probability mass functions on any sample space X n and F = {fφ :
φ ∈ Φ} ⊂ E a parametric family of probability mass functions on X n for the Φ. For
given data vector x, a member of X n, the regret of a predictive mass function f¯ ∈ E is
a measure of how well f¯ predicts the sample vector x. The regret is defined as
reg(f¯ , x; Φ) = log
fφˆ(x)(x)
f¯(x)
(5)
where φˆ(x) is the maximum likelihood estimate (MLE) with respect to the Φ under the
observed data vector x (Gru¨nwald, 2007; Bickel, 2010b).
For all predictive probability mass functions in E , the optimal predictive probability
mass function, denoted as f †, minimizes the maximal regret in the sample space X n in
the sense that it satisfies
f † = arg inf
f¯∈E
sup
x∈Xn
reg(f¯ , x; Φ). (6)
The optimal probability mass function evaluated the observed data vector is called the
normalized maximum likelihood (NML). It is well known (Gru¨nwald, 2007) that the
formula of the predictive probability mass function that satisfies equation (6) is
f † = f †(•; Φ) =
fφˆ(•)(•)∑
y∈Xn fφˆ(y)(y)
. (7)
The logarithm of the denominator of (7) is called the parametric complexity (Barron
et al., 1998) and is log
∫
Xn fφˆ(y)(y)dy if X is continuous and if f is a probability density
function.
Based on the definition and formulas of the NML provided above, the NML is an
optimal predictive function over all predictive functions and samples on Φ. Taking the
logarithm of the equation (7), the log-NML is the logarithm of the maximum likelihood
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Table 6: Base-2 scale of evidence Bickel (2010b)
log2Ev Ev Evidence against H0
(0, 1) (1, 2) Negligible
[1, 2) [2, 4) Weak
[2, 3) [4, 8) Moderate
[3, 5) [8, 32) Strong
[5, 7) [32, 128) Very strong
[7,∞) [128,∞) Overwhelming
of the parameter minus a penalty constant (the parametric complexity), i.e.,
log f † = log fφˆ(x)(x)− log
∑
y∈Xn
fφˆ(y)(y). (8)
Therefore, compared to the maximum likelihood, the NML tends to counteract overfit-
ting. We can treat the logarithm of the ratio of NML for the alternative hypothesis over
the NML for the null hypothesis as the discrimination information based on the normal-
ized maximum likelihood (DINML) (Bickel, 2010b) to measure the strength of evidence
in favor of the alternative hypothesis against the null hypothesis, i.e.,
DINML = log Ev = log
f †1(x; Φ1)
f †0(x; Φ0)
(9)
= − log f †0(x; Φ0)− (− log f †1(x; Φ1)).
Bickel (2010b) adapted the heuristic grades of evidence of Table 4 to the binary logarithm
(log2) (Table 6).
3 Gene enrichment methods
Considering Tables 1 and 2, let X1 and X2 be two random numbers of DE genes and
EE genes in a GO category. Both of them follow the binomial distribution, i.e., X1 ∼
Binomial(n1, pi1) and X2 ∼ Binomial(n2, pi2), where pi1 = pi11/pi·1 is the proportion ratio
9
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of DE genes in the category over all DE genes and pi2 = pi12/pi·2 is the proportion ratio
of EE genes in the category over all EE genes. If X1 and X2 are independent, the
unconditional likelihood is
L(pi1, pi2;x1, x2)
= P (X1 = x1, X2 = x2;pi1, pi2)
=
(
n1
x1
)(
n2
x2
)
pix11 (1− pi1)n1−x1pix22 (1− pi2)n2−x2
(10)
where 0 ≤ xi ≤ ni and 0 ≤ pii ≤ 1, i = 1, 2.
3.1 Hypothesis comparison
The objective of a one-sided hypothesis comparison is to determine whether genes in
the gene list are overrepresented (enriched) in a specified GO category of interest as
opposed to underrepresented (depleted) in that category, i.e., we want to know whether
the proportion of genes in both the gene list and the GO category is higher or whether
it is lower than the proportion of genes are in the GO category but out of the gene list.
Therefore, our hypotheses are
H0 : pi1 ≤ pi2 vs. H1 : pi1 > pi2. (11)
Consider the two-sided hypothesis comparison. The objective is to determine whether
genes are either overrepresented or under-represented in a specified GO category or
whether they are neither overrepresented nor underrepresented, in which case the hy-
potheses are
H0 : pi1 = pi2 = pi vs. H1 : pi1 6= pi2. (12)
10
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For the one-sided comparisons, negative values of DI correspond to evidence in favor
of underrepresentation, whereas for the two-sided comparisons, negative values of DI
correspond to evidence in favor of the hypothesis that there is neither overrepresentation
nor underrepresentation.
3.2 Bayes factor
3.2.1 One-sided hypothesis comparison
Based on the equation (4), the Bayes factor formula for our gene enrichment problem
under the hypothesis shown in (11) is
BF =
∫∫
0≤pi2<pi1≤1 L(pi1, pi2;x1, x2) · g(pi1, pi2)dpi1dpi2∫∫
0≤pi1≤pi2≤1 L(pi1, pi2;x1, x2) · g(pi1, pi2)dpi1dpi2
(13)
where L(pi1, pi2;x1, x2) is the likelihood shown in equation (10); g(pi1, pi2) is the prior
distribution of the parameter pair (pi1, pi2) and x1, x2, n1, n2 are defined in Table 1.
3.2.2 Two-sided hypothesis comparison
Based on the equation (4), the Bayes factor formula for our gene enrichment problem
under the hypothesis shown in (12) is
BF =
∫ 1
pi1=0
∫ 1
pi2=0
L(pi1, pi2;x1, x2) · g1(pi1, pi2)dpi1dpi2∫ 1
pi=0 L(pi, pi;x1, x2) · g0(pi)dpi
(14)
where L(pi1, pi2;x1, x2) is the likelihood shown in equation (10); g1(pi1, pi2) and g0(pi) are
prior densities of the parameters (pi1, pi2), pi; x1, x2, n1, n2 are defined in Table 1.
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3.2.3 Prior distribution
Considering the BF of the gene enrichment problem, we follow the convention of using
a beta distribution as the prior, i.e.,
g(pi1, pi2) =
piα1−11 (1− pi1)β1−1piα2−12 (1− pi2)β2−1
B(α1, β1)B(α2, β2)
(15)
for the BF computed by the equation (13) and chose g1(pi1, pi2) = g(pi1, pi2) and
g0(pi) =
piα0−1(1− pi)β0−1
B(α0, β0)
(16)
for the BF computed by the equation (14) where the B(α, β) in equations (15) and (16)
is formed by
B(α, β) =
Γ(α)Γ(β)
Γ(α+ β)
.
3.3 Normalized maximum unconditional likelihood
If we define λ = ln[pi2/(1 − pi2)] and θ = ln[pi1/(1 − pi1)] − λ, then θ is the parameter
of interest, representing the logarithm of odds ratio of the gene enrichment and λ is a
nuisance parameter. The hypothesis comparisons (11) and (12) are equivalent to
H0 : θ ≤ 0 vs. H1 : θ > 0 (17)
and
H0 : θ = 0 vs. H1 : θ 6= 0. (18)
Let Θ denote the set of possible values of the interest parameter and Λ be the set
of possible values of the nuisance parameter. Under the new parameterization, the
12
http://biostats.bepress.com/cobra/art76
unconditional likelihood function (10) is
L(θ, λ;x1, x2,Θ,Λ) =
(
n1
x1
)(
n2
x2
) · ex1(θ+λ)ex2λ
(1 + eθ+λ)n1(1 + eλ)n2
(19)
where 0 ≤ xi ≤ ni (i = 1, 2).
In analogy with equation (6.15) in Barron et al. (1998, §6.2.1), the normalized max-
imum unconditional likelihood (NMUL) under the hypothesis H: θ ∈ Θ˜ ⊂ Θ is
L†(θ, λ;x1, x2, Θ˜,Λ) =
L(θˆ(x1, x2), λˆ(x1, x2);x1, x2, Θ˜,Λ)
K(Θ˜,Λ) (20)
where K†(Θ˜,Λ) is defined as
K†(Θ˜,Λ) =
n1∑
y1=0
n2∑
y2=0
L(θˆ(y1, y2), λˆ(y1, y2); y1, y2, Θ˜,Λ) (21)
and θˆ(x1, x2), θˆ(y1, y2), λˆ(x1, x2), λˆ(y1, y2) are MLEs of parameters θ and λ in Θ˜ and Λ.
Bryant and Cordero-Brana (2000) reported, a general formula of computing the NML
based on the multinomial model for testing the independence in a contingency table.
This formula is equivalent to our NMUL formula shown in the equation (21) under the
two-sided hypothesis comparison represented in (18) for a 2× 2 contingency table.
The discrimination information of NMUL (DINMUL) supporting the alternative hy-
pothesis H1 : θ ∈ Θ1 over the null hypothesis H0 : θ ∈ Θ0 is
DINMUL = log
L†(θ, λ;x1, x2,Θ1,Λ)
L†(θ, λ;x1, x2,Θ0,Λ)
(22)
= log
L(θˆ(x1, x2), λˆ(x1, x2);x1, x2,Θ1,Λ)/K†(Θ1,Λ)
L(θˆ(x1, x2), λˆ(x1, x2);x1, x2,Θ0,Λ)/K†(Θ0,Λ)
.
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3.4 Normalized maximum conditional likelihood
In the Section 3.3, we take both the interest parameter θ and the nuisance parameter
λ into consideration and construct the DINMUL, shown in the equation (22), to obtain
the strength of evidence supporting the alternative hypothesis over the null hypothesis
which are represented by the parameter of interest θ. However, DINMUL depends on
the value of the nuisance parameter λ. In this section, we use a conditional likelihood
function to eliminate the value of the nuisance parameter λ from the likelihood function
to improve the reliability of the DI.
Consider a function S of X1 and X2 such that S(X1, X2) = X1 +X2. The probability
mass function evaluated at S(x1, x2) = x1 +x2 = s, say f(T (x1, x2) = t; θ, λ|S(x1, x2) =
s), does not depend on the nuisance parameter λ (see Severini (2000, Example 8.47),
Bickel (2010a)). Taking the statistic T (X1, X2) = X1, we get the conditional probability
mass function :
f(T = t; θ ∈ Θ|S = s) =
(
n1
t
)(
n2
s−t
)
etθ∑min(s,n1)
j=max(0,s−n2)
(
n1
j
)(
n2
s−j
)
ejθ
. (23)
Similar to Section 3.3, in analogy with equation (6.15) in Barron et al. (1998, §6.2.1),
the normalized maximum conditional likelihood (NMCL) under the hypothesis H : θ ∈
Θ˜ ⊂ Θ is
L‡S(θ;T = t, Θ˜) =
maxθ∈Θ˜ f(T = t; θ ∈ Θ˜|S = s)
K‡S(Θ˜)
(24)
where K‡S(Θ˜) is a constant and defined as
K‡S(Θ˜) =
min(s,n1)∑
y=max(0,s−n2)
max
θ∈Θ˜
f(T = y; θ ∈ Θ˜|S = s) (25)
=
min(s,n1)∑
y=max(0,s−n2)
(
n1
y
)(
n2
s−y
)
eyθˆ(y)∑min(s,n1)
j=max(0,s−n2)
(
n1
j
)(
n2
s−j
)
ejθˆ(y)
14
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where
θˆ(y) = arg max
θ∈Θ˜
f(T = y; θ ∈ Θ˜|S = s). (26)
Therefore, the discrimination information of NMCL (DINMCL) supporting the alterna-
tive hypothesis H1 : θ ∈ Θ1 over the null hypothesis H0 : θ ∈ Θ0 is
DINMCL = log
L‡S(θ;T = t,Θ1)
L‡S(θ;T = t,Θ0)
. (27)
Since the nuisance parameter is eliminated, we can reduce the data vector x by con-
sidering a statistic T (x1, x2) instead of the data x1, x2. However, the use of DINMCL as
a measure of statistical evidence for enrichment or depletion requires some justification
due to concerns about losing information in the conditioning process. Unfortunately,
the statistic S(X1, X2) = X1 + X2 is not an ancillary statistic for the interest param-
eter in the presence of the nuisance parameter. In other words, the probability mass
function of the conditional variable S(X1, X2) may contain some information about the
interest parameter θ (Severini, 2000). Following the explanation of Barndorff-Nielsen
and Cox (Barndorff-Nielsen and Cox (1994), §2.5), the expectation value of the statis-
tic S(X1, X2) equals the nuisance parameter, i.e., E(S(X1, X2)) = λ. Hence, from the
observation of S(X1, X2) alone, the distribution of the statistic S(X1, X2) contains lit-
tle information about the interest parameter θ (Barndorff-Nielsen and Cox, 1994). The
statistic S(X1, X2) satisfies the other three conditions of an ancillary statistic given
by Barndorff-Nielsen and Cox (1994): parameters θ and λ are variation independent;
the statistic (T (X1, X2), S(X1, X2)) is the minimal sufficient statistic; the distribution of
the statistic T (X1, X2) given S(X1, X2) = s is independent given the nuisance parameter
λ. Therefore, the probability mass function of the statistic S(X1, X2) contains a little
information about the value of the interest parameter θ.
15
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4 Application
In this section, we apply NMUL and NMCL presented in Section 2.2.2 to analyze cancer
gene expression data. We focus on the two hypothesis comparisons, namely, the hypoth-
esis comparisons (11) and (12). For each hypothesis comparison, we computed DINMUL
and DINMCL as the strengths of evidence supporting the alternative hypothesis over the
null hypothesis and then compared them to other evidence measures, the Bayes factor
and the Fisher’s p-value.
4.1 Gene expression data
The data set we used is from an experiment applying an estrogen treatment to cells
of a human breast cancer cell line (Scholtens et al., 2004). It is available from the
Bioconductor project, containing 8 Affymetrix HG-U95Av2 CEL files from an estrogen
receptor positive breast cancer cell line. See Gentleman et al. (2005) for more detail
about the data and the Bioconductor project. We used 12, 625 probes expressed in
the microarray experiment as a reference and chose 38 probes at the single time point
48 hours (48h) as gene lists to study such that their local false discovery rate (LFDR)
estimates from a parametric mixture model (PMM) (Yang and Bickel, 2010) are no
larger than the cutoff threshold 0.05. This approach yielding the gene list is specified
in Section 4.2. Based on Table 1, we obtained n1 = 38 and n1 + n2 = 12, 625. For
simplicity of terminology, we consider probes in the microarray experiment as genes.
4.2 Gene list
The following method of obtaining LFDR estimates of a PMM appeared in Yang and
Bickel (2010) in the context of genome-wide association studies. Consider the PMM of
the ith gene in the microarray data set, i.e.,
fPMM(ti) = pi0f0(ti) + (1− pi0)fδ(ti) (28)
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where fδ is a density function of the absolute value of a variate that has a noncentral
t distribution with two degrees of freedom and the noncentrality parameter δ; ti is the
absolute value of the t statistic of the ith gene; pi0 is the probability of EE. The log-
likelihood under the PMM over all genes in a microarray data set is
logL(pi0, δ) =
N∑
i=1
log fPMM(ti) (29)
where pi0, δ and ti are defined as in equation (28); N is the total number of genes. The
LFDR estimate of the ith gene is computed by
L̂FDR(ti) =
pˆi0f0(ti)
pˆi0f0(ti) + (1− pˆi0)fδˆ(ti)
(30)
where pˆi0 and δˆ are MLEs of pi0 and δ in equation (29).
The 38 genes in the microarray data at 48h were obtained by requiring that their
LFDR estimates be no larger than the threshold 0.05 to construct the gene list.
4.3 Gene Ontology (GO) categories
The set of GO categories we chose for our gene enrichment problem is all the unrelated
GO categories that contain at least one gene in the gene list. GO categories are unrelated
in sense that there are no common ancestors between any pair of them. The 209 GO
categories at 48h were obtained as the GO category set.
4.4 Measure comparisons
Using the Fisher’s p-value as a measure of the strength of evidence supporting the
alternative hypothesis over the null hypothesis mentioned in Section 3.1 and Section 3.3
is an easy and fast way to address the gene enrichment problem. We compare the p-value
to DINMUL (or DINMCL) as the measure in favor of the alternative hypothesis against the
17
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null hypothesis shown in Section 3.1 and Section 3.3. Figure 1 represents the negative
binary logarithm of the p-value vs. the DINMUL (or DINMCL) over all 209 GO categories.
DINMUL and DINMCL are two measures of the strength of evidence in the hypothesis
comparison. Computing DINMUL is easier and faster than computing DINMCL because
the term shown in (21) is much simpler than that shown in (25). However, as a measure,
DINMCL is more reliable than DINMUL because DINMUL does not eliminate the nuisance
parameter before minimax optimization. Figure 4 (left and centre) shows the comparison
of DINMUL and DINMCL over all 209 GO categories.
We also compared DINMUL (or DINMCL) to the DI based on the Bayes factor (DIBF),
i.e., the binary logarithm of the BF, by choosing beta distributions as prior distributions
of parameters. Figure 3 shows DINMUL (or DINMCL) vs. DIBF with the Jeffreys or
uniform prior for each beta distribution, i.e., all parameters of beta distributions in (15)
and (16) are 0.5 (Jeffreys prior) or 1 (uniform prior) under one-sided and two-sided
hypothesis comparisons.
More precisely, to obtain the coincidence between two measures of evidence, we
calculated the proportion of agreement between two measures, i.e., the proportion that
of all GO terms that yield the same level of evidence. For instance, considering strong
(or stronger) evidence, we obtain the threshold of the p-value to be 0.01 according to
Table 3; the threshold of the DINMUL is 3 according to the Table 6. Similarly, we
say evidence measured by the DINMUL is strong or not is based on whether DINMUL is
larger than 3. Figure 2 shows the proportions of agreement under measure comparisons:
DINMUL (or DINMCL) vs. the p-value, DINMUL (or DINMCL) vs. DIBF with the Jeffreys
prior for each beta distribution and DINMUL vs. DINMCL.
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Figure 1: The negative binary logarithm of the p-value vs. DINMUL and DINMCL for the
one-sided and two-sided hypothesis comparisons. The dash lines are thresholds of strong
or stronger, very strong or stronger and overwhelming evidence based on the p-value,
NMUL and NMCL.
Figure 2: Proportion of agreement for measure comparisons DINMUL vs. p-value (◦ in
the left plot), DINMUL vs. DIBF (◦ in the centre plot), DINMUL vs. DINMCL (◦ in the
right plot) under the one-sided hypothesis comparison; DINMUL vs. p-value (4 in the
left plot), DINMUL vs. DIBF (4 in the centre plot), DINMUL vs. DINMCL (4 in the right
plot) under the two-sided hypothesis comparison; DINMCL vs. p-value (+ in the left plot)
or DIBF (+ in the centre plot) under the one-sided hypothesis comparison; DINMUL vs.
p-value (× in the left plot) or DIBF (× in the centre plot) under the two-sided hypothesis
comparison.
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Figure 3: DINMUL and DINMCL vs. DIBF with the beta prior distribution. Beta(m,m)
means α1 = α2 = β1 = β2 = m for top two plots and α0 = α1 = α2 = β0 = β1 = β2 = m
for bottom two plots, where αi and βi, i = 0, 1, 2 are defined in equation (15) and (16).
The horizontal and vertical dash lines are thresholds of strong or stronger, very strong
or stronger and overwhelming evidence based on BF, NMUL and NMCL.
Figure 4: DINMUL vs. DINMCL for one-sided and two-sided hypothesis comparison. The
horizontal and vertical dash lines are thresholds of strong or stronger, very strong or
stronger, overwhelming evidence based on NMUL and NMCL.
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5 Conclusions
In this paper, we proposed addressing the gene overrepresentation problem using the
NMUL and NMCL. As the strength of evidence in favor of one hypothesis against the
other, DINMUL and DINMCL, like the Bayes factor, are more interpretable than the
p-value. Compared with DIBF, instead of using the integrated likelihood over all pa-
rameters, DINMUL and DINMCL use the optimal predictive probability mass (or density)
function, which minimizes the maximal regret over all predictive mass functions and
data. See equation (5) and equation (6). Comparing DINMUL to DINMCL, we conclude
that DINMCL is more reliable because the nuisance parameter is eliminated without
substantial loss of information.
Furthermore, consider the comparisons DINMUL (or DINMCL) vs. the p-value (shown
in Figure 1 and Figure 2 (left)); DINMUL (or DINMCL) vs. DIBF (shown in Figure 3 and
Figure 2 (centre)); DINMUL vs. DINMCL based on the data set represented in Section 4.1.
The measures p-value, DIBF, DINMUL and DINMCL usually give the same results for two-
sided hypothesis comparison when stringent evidence thresholds are employed, which
suggests the possibility that under certain conditions we can use the conclusions based
on any of the first three measures to approximate that based on the DINMCL. However,
the measures of evidence do not agree as well if we choose a threshold of a lower level
evidence or if we consider the one-sided hypothesis comparison, in which case the DINMCL
cannot be approximated by any of the more computationally efficient methods.
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